_id
6919ecf13c536f8df2318429
Ticker
PRTC.LSE
Name
PureTech Health plc
Exchange
LSE
Address
6 Tide Street, Boston, MA, United States, 02210
Country
UK
Sector
Healthcare
Industry
Biotechnology
Currency
GBX
Website
https://www.puretechhealth.com
Description
PureTech Health plc, engages in the development and commercialization of biotechnology and pharmaceutical solutions in the United States. It is developing LYT-100, which is under Phase 2 stage, to treat idiopathic pulmonary fibrosis (IPF); and LYT-200, a IgG4 monoclonal antibody, currently under Phase 1/2 stage, targeting galectin-9 for treating solid tumors and hematological malignancies. The company also develops SPT-300, an oral drug of allopregnanolone for the treatment of anxious depression; and delivers transformative medicines for patients with psychiatric and neurological conditions. In addition, the company develops hydrogels to enable the oral administration of peptide therapeutics in preclinical development; oral therapies based on defined bacterial consortia that is in phase 3 clinical stage; and engineering hematopoietic stem cells to enable targeted therapies for patients with blood cancers. Further, it develops voice-based technology platform that detects changes in the sound of voice that are linked with health conditions, including depression, anxiety, and respiratory disease. The company was incorporated in 2015 and is based in Boston, Massachusetts.
Last Close
1278000
Volume
146995
Current Price
134.504
Change
-0.6259780907668209
Last Updated
2025-12-30T11:24:24.305Z
Image
https://logo.clearbit.com/www.puretechhealth.com
Ipo Date
-
Market Cap
308872192
Next Dividend Date
-
Dividend Frequency
-
Dividend Rate
-
Dividend Yield
0
Sentiment
-
Sentiment Sources
0
Rating
4
Strong Buy
0
Buy
1
Hold
0
Sell
0
Strong Sell
0
Current Quarter
2025-06-30
Revenue
1851000
Cost Of Revenue
24900000
Gross Profit
-23049000
Operating Expenses
24882000
Operating Income
-47931000
Interest Expense
-
Pretax Income
-43858000
Net Income
-44605000
Eps
-0.1858819002461834
Dividends Per Share
-
Shares Outstanding
241684038
Income Tax Expense
923000
EBITDA
-46240000
Operating Margin
-2589.4651539708266
Total Other Income Expense Net
4073000
Cash
260604000
Short Term Investments
60947000
Receivables
13863000
Inventories
-
Total Current Assets
344388000
Property Plant Equipment
13314000
Total Assets
553242000
Payables
4698000
Short Term Debt
7989000
Long Term Debt
-
Total Liabilities
184217000
Equity
375975000
Bs_currency_symbol
USD
Depreciation
1692000
Change In Working Capital
-304000
Cash From Operations
-45942000
Capital Expenditures
0
Cash From Investing
29679000
Cash From Financing
-3775000
Net Change In Cash
260603999
Cf_currency_symbol
-
PE
9.8308
PB
85.84651554163973
ROE
-11.863820732761486
ROA
-8.062475372440993
FCF
-45942000
Fcf Percent
-24.820097244732576
Piotroski FScore
0
Health Score
26
Deep Value Investing Score
7
Defensive Investing Score
7
Dividend Investing Score
1.5
Economic Moat Investing Score
4.3
Garp Investing Score
2.5
Growth Investing Score
1.5
Momentum Investing Score
5
Net Net Investing Score
3.5
Quality Investing Score
3
Value Investing Score
6
Quarters > 0 > quarter
2025-06-30
Quarters > 0 > income Statement > revenue
1851000
Quarters > 0 > income Statement > cost Of Revenue
24900000
Quarters > 0 > income Statement > gross Profit
-23049000
Quarters > 0 > income Statement > operating Expenses
24882000
Quarters > 0 > income Statement > operating Income
-47931000
Quarters > 0 > income Statement > interest Expense
-
Quarters > 0 > income Statement > pretax Income
-43858000
Quarters > 0 > income Statement > net Income
-44605000
Quarters > 0 > income Statement > eps
-0.1858819002461834
Quarters > 0 > income Statement > dividends Per Share
-
Quarters > 0 > income Statement > shares Outstanding
239964192
Quarters > 0 > income Statement > income Tax Expense
923000
Quarters > 0 > income Statement > EBITDA
-46240000
Quarters > 0 > income Statement > operating Margin
-2589.4651539708266
Quarters > 0 > income Statement > total Other Income Expense Net
4073000
Quarters > 0 > income Statement > currency_symbol
-
Quarters > 0 > balance Sheet > cash
260604000
Quarters > 0 > balance Sheet > short Term Investments
60947000
Quarters > 0 > balance Sheet > receivables
13863000
Quarters > 0 > balance Sheet > inventories
-
Quarters > 0 > balance Sheet > total Current Assets
344388000
Quarters > 0 > balance Sheet > property Plant Equipment
13314000
Quarters > 0 > balance Sheet > total Assets
553242000
Quarters > 0 > balance Sheet > payables
4698000
Quarters > 0 > balance Sheet > short Term Debt
7989000
Quarters > 0 > balance Sheet > long Term Debt
-
Quarters > 0 > balance Sheet > total Liabilities
184217000
Quarters > 0 > balance Sheet > equity
375975000
Quarters > 0 > balance Sheet > currency_symbol
USD
Quarters > 0 > cash Flow > net Income
-44605000
Quarters > 0 > cash Flow > depreciation
1692000
Quarters > 0 > cash Flow > change In Working Capital
-304000
Quarters > 0 > cash Flow > cash From Operations
-45942000
Quarters > 0 > cash Flow > capital Expenditures
0
Quarters > 0 > cash Flow > cash From Investing
29679000
Quarters > 0 > cash Flow > cash From Financing
-3775000
Quarters > 0 > cash Flow > net Change In Cash
260603999
Quarters > 0 > cash Flow > currency_symbol
-
Quarters > 0 > ratios > PE
-0.1858819002461834
Quarters > 0 > ratios > PB
85.84651554163973
Quarters > 0 > ratios > ROE
-11.863820732761486
Quarters > 0 > ratios > ROA
-8.062475372440993
Quarters > 0 > ratios > FCF
-45942000
Quarters > 0 > ratios > Piotroski FScore
0
Quarters > 0 > ratios > fcf Percent
-24.820097244732576
Quarters > 0 > health Score
26
Quarters > 1 > quarter
2024-12-31
Quarters > 1 > income Statement > revenue
4027000
Quarters > 1 > income Statement > cost Of Revenue
-38928000
Quarters > 1 > income Statement > gross Profit
42955000
Quarters > 1 > income Statement > operating Expenses
112652000
Quarters > 1 > income Statement > operating Income
-69697000
Quarters > 1 > income Statement > interest Expense
10037000
Quarters > 1 > income Statement > pretax Income
78805000
Quarters > 1 > income Statement > net Income
95283000
Quarters > 1 > income Statement > eps
0.35334951030778333
Quarters > 1 > income Statement > dividends Per Share
-
Quarters > 1 > income Statement > shares Outstanding
269656522
Quarters > 1 > income Statement > income Tax Expense
2139000
Quarters > 1 > income Statement > EBITDA
101966000
Quarters > 1 > income Statement > operating Margin
-1730.742488204619
Quarters > 1 > income Statement > total Other Income Expense Net
148502000
Quarters > 1 > income Statement > currency_symbol
-
Quarters > 1 > balance Sheet > cash
280641000
Quarters > 1 > balance Sheet > short Term Investments
86666000
Quarters > 1 > balance Sheet > receivables
12903000
Quarters > 1 > balance Sheet > inventories
-
Quarters > 1 > balance Sheet > total Current Assets
386256000
Quarters > 1 > balance Sheet > property Plant Equipment
15129000
Quarters > 1 > balance Sheet > total Assets
602635000
Quarters > 1 > balance Sheet > payables
5522000
Quarters > 1 > balance Sheet > short Term Debt
7690000
Quarters > 1 > balance Sheet > long Term Debt
-
Quarters > 1 > balance Sheet > total Liabilities
194702000
Quarters > 1 > balance Sheet > equity
414707000
Quarters > 1 > balance Sheet > currency_symbol
USD
Quarters > 1 > cash Flow > net Income
69555000
Quarters > 1 > cash Flow > depreciation
1757000
Quarters > 1 > cash Flow > change In Working Capital
-10162000
Quarters > 1 > cash Flow > cash From Operations
-54355000
Quarters > 1 > cash Flow > capital Expenditures
11000
Quarters > 1 > cash Flow > cash From Investing
4376000
Quarters > 1 > cash Flow > cash From Financing
22143000
Quarters > 1 > cash Flow > net Change In Cash
221942500
Quarters > 1 > cash Flow > currency_symbol
-
Quarters > 1 > ratios > PE
0.35334951030778333
Quarters > 1 > ratios > PB
87.45905141482541
Quarters > 1 > ratios > ROE
22.975980632108936
Quarters > 1 > ratios > ROA
15.811063081301285
Quarters > 1 > ratios > FCF
-54366000
Quarters > 1 > ratios > Piotroski FScore
2
Quarters > 1 > ratios > fcf Percent
-13.50037248572138
Quarters > 1 > health Score
66
Quarters > 2 > quarter
2024-06-30
Quarters > 2 > income Statement > revenue
288000
Quarters > 2 > income Statement > cost Of Revenue
38928000
Quarters > 2 > income Statement > gross Profit
-38640000
Quarters > 2 > income Statement > operating Expenses
27757998
Quarters > 2 > income Statement > operating Income
-66397998
Quarters > 2 > income Statement > interest Expense
-
Quarters > 2 > income Statement > pretax Income
-55031000
Quarters > 2 > income Statement > net Income
-41773000
Quarters > 2 > income Statement > eps
-0.1549118845343559
Quarters > 2 > income Statement > dividends Per Share
-
Quarters > 2 > income Statement > shares Outstanding
269656522
Quarters > 2 > income Statement > income Tax Expense
-6147000
Quarters > 2 > income Statement > EBITDA
-64584000
Quarters > 2 > income Statement > operating Margin
-23054.860416666666
Quarters > 2 > income Statement > total Other Income Expense Net
11366998
Quarters > 2 > income Statement > currency_symbol
-
Quarters > 2 > balance Sheet > cash
308478000
Quarters > 2 > balance Sheet > short Term Investments
191938000
Quarters > 2 > balance Sheet > receivables
2055000
Quarters > 2 > balance Sheet > inventories
4703000
Quarters > 2 > balance Sheet > total Current Assets
508810000
Quarters > 2 > balance Sheet > property Plant Equipment
17336000
Quarters > 2 > balance Sheet > total Assets
579950000
Quarters > 2 > balance Sheet > payables
8125000
Quarters > 2 > balance Sheet > short Term Debt
10853000
Quarters > 2 > balance Sheet > long Term Debt
-
Quarters > 2 > balance Sheet > total Liabilities
273744000
Quarters > 2 > balance Sheet > equity
315867000
Quarters > 2 > balance Sheet > currency_symbol
USD
Quarters > 2 > cash Flow > net Income
-41773000
Quarters > 2 > cash Flow > depreciation
1814000
Quarters > 2 > cash Flow > change In Working Capital
-74000
Quarters > 2 > cash Flow > cash From Operations
-80014000
Quarters > 2 > cash Flow > capital Expenditures
0
Quarters > 2 > cash Flow > cash From Investing
236512000
Quarters > 2 > cash Flow > cash From Financing
-39101000
Quarters > 2 > cash Flow > net Change In Cash
58698500
Quarters > 2 > cash Flow > currency_symbol
-
Quarters > 2 > ratios > PE
-0.1549118845343559
Quarters > 2 > ratios > PB
114.82643275520391
Quarters > 2 > ratios > ROE
-13.224869961091217
Quarters > 2 > ratios > ROA
-7.202862315716872
Quarters > 2 > ratios > FCF
-80014000
Quarters > 2 > ratios > Piotroski FScore
0
Quarters > 2 > ratios > fcf Percent
-277.8263888888889
Quarters > 2 > health Score
22
Quarters > 3 > quarter
2024-03-31
Quarters > 3 > income Statement > revenue
144000
Quarters > 3 > income Statement > cost Of Revenue
19464000
Quarters > 3 > income Statement > gross Profit
-19320000
Quarters > 3 > income Statement > operating Expenses
13878999
Quarters > 3 > income Statement > operating Income
-33198999
Quarters > 3 > income Statement > interest Expense
-
Quarters > 3 > income Statement > pretax Income
-27515500
Quarters > 3 > income Statement > net Income
-20886500
Quarters > 3 > income Statement > eps
-0.07745594226717795
Quarters > 3 > income Statement > dividends Per Share
-
Quarters > 3 > income Statement > shares Outstanding
269656522
Quarters > 3 > income Statement > income Tax Expense
3073500
Quarters > 3 > income Statement > EBITDA
-32292000
Quarters > 3 > income Statement > operating Margin
-23054.860416666666
Quarters > 3 > income Statement > total Other Income Expense Net
5683499
Quarters > 3 > income Statement > currency_symbol
-
Quarters > 3 > balance Sheet > cash
308478000
Quarters > 3 > balance Sheet > short Term Investments
191938000
Quarters > 3 > balance Sheet > receivables
2055000
Quarters > 3 > balance Sheet > inventories
4703000
Quarters > 3 > balance Sheet > total Current Assets
508810000
Quarters > 3 > balance Sheet > property Plant Equipment
17336000
Quarters > 3 > balance Sheet > total Assets
579950000
Quarters > 3 > balance Sheet > payables
8125000
Quarters > 3 > balance Sheet > short Term Debt
10853000
Quarters > 3 > balance Sheet > long Term Debt
-
Quarters > 3 > balance Sheet > total Liabilities
273744000
Quarters > 3 > balance Sheet > equity
315867000
Quarters > 3 > balance Sheet > currency_symbol
-
Quarters > 3 > cash Flow > net Income
-20886500
Quarters > 3 > cash Flow > depreciation
907000
Quarters > 3 > cash Flow > change In Working Capital
-37000
Quarters > 3 > cash Flow > cash From Operations
-40007000
Quarters > 3 > cash Flow > capital Expenditures
0
Quarters > 3 > cash Flow > cash From Investing
-
Quarters > 3 > cash Flow > cash From Financing
-19550500
Quarters > 3 > cash Flow > net Change In Cash
58698500
Quarters > 3 > cash Flow > currency_symbol
-
Quarters > 3 > ratios > PE
-0.07745594226717795
Quarters > 3 > ratios > PB
114.82643275520391
Quarters > 3 > ratios > ROE
-6.612434980545609
Quarters > 3 > ratios > ROA
-3.601431157858436
Quarters > 3 > ratios > FCF
-40007000
Quarters > 3 > ratios > Piotroski FScore
0
Quarters > 3 > ratios > fcf Percent
-277.8263888888889
Quarters > 3 > health Score
22
Annuals > 0 > quarter
2024-12-31
Annuals > 0 > income Statement > revenue
4315000
Annuals > 0 > income Statement > cost Of Revenue
-
Annuals > 0 > income Statement > gross Profit
4315000
Annuals > 0 > income Statement > operating Expenses
140410000
Annuals > 0 > income Statement > operating Income
-136095000
Annuals > 0 > income Statement > interest Expense
10037000
Annuals > 0 > income Statement > pretax Income
23774000
Annuals > 0 > income Statement > net Income
53510000
Annuals > 0 > income Statement > eps
0.19843762577342744
Annuals > 0 > income Statement > dividends Per Share
-
Annuals > 0 > income Statement > shares Outstanding
269656522
Annuals > 0 > income Statement > income Tax Expense
-4008000
Annuals > 0 > income Statement > EBITDA
37382000
Annuals > 0 > income Statement > operating Margin
-3153.997682502897
Annuals > 0 > income Statement > total Other Income Expense Net
159869000
Annuals > 0 > income Statement > currency_symbol
USD
Annuals > 0 > balance Sheet > cash
280641000
Annuals > 0 > balance Sheet > short Term Investments
86666000
Annuals > 0 > balance Sheet > receivables
12903000
Annuals > 0 > balance Sheet > inventories
-
Annuals > 0 > balance Sheet > total Current Assets
386256000
Annuals > 0 > balance Sheet > property Plant Equipment
15129000
Annuals > 0 > balance Sheet > total Assets
602635000
Annuals > 0 > balance Sheet > payables
5522000
Annuals > 0 > balance Sheet > short Term Debt
7690000
Annuals > 0 > balance Sheet > long Term Debt
-
Annuals > 0 > balance Sheet > total Liabilities
194702000
Annuals > 0 > balance Sheet > equity
414707000
Annuals > 0 > balance Sheet > currency_symbol
USD
Annuals > 0 > cash Flow > net Income
27782000
Annuals > 0 > cash Flow > depreciation
3571000
Annuals > 0 > cash Flow > change In Working Capital
-10236000
Annuals > 0 > cash Flow > cash From Operations
-134369000
Annuals > 0 > cash Flow > capital Expenditures
11000
Annuals > 0 > cash Flow > cash From Investing
240888000
Annuals > 0 > cash Flow > cash From Financing
-16958000
Annuals > 0 > cash Flow > net Change In Cash
89560000
Annuals > 0 > cash Flow > currency_symbol
USD
Annuals > 0 > ratios > PE
0.19843762577342744
Annuals > 0 > ratios > PB
82.89310944257994
Annuals > 0 > ratios > ROE
12.903085793102118
Annuals > 0 > ratios > ROA
8.879338239564579
Annuals > 0 > ratios > FCF
-134380000
Annuals > 0 > ratios > Piotroski FScore
2
Annuals > 0 > ratios > fcf Percent
-31.14252607184241
Annuals > 0 > health Score
60
Annuals > 1 > quarter
2023-12-31
Annuals > 1 > income Statement > revenue
750000
Annuals > 1 > income Statement > cost Of Revenue
93655000
Annuals > 1 > income Statement > gross Profit
-92905000
Annuals > 1 > income Statement > operating Expenses
53294000
Annuals > 1 > income Statement > operating Income
-146199000
Annuals > 1 > income Statement > interest Expense
13488000
Annuals > 1 > income Statement > pretax Income
-36103000
Annuals > 1 > income Statement > net Income
-65697000
Annuals > 1 > income Statement > eps
-0.23777197873173317
Annuals > 1 > income Statement > dividends Per Share
-
Annuals > 1 > income Statement > shares Outstanding
276302533
Annuals > 1 > income Statement > income Tax Expense
30525000
Annuals > 1 > income Statement > EBITDA
-17681000
Annuals > 1 > income Statement > operating Margin
-19493.199999999997
Annuals > 1 > income Statement > total Other Income Expense Net
110096000
Annuals > 1 > income Statement > currency_symbol
USD
Annuals > 1 > balance Sheet > cash
191081000
Annuals > 1 > balance Sheet > short Term Investments
136062000
Annuals > 1 > balance Sheet > receivables
2376000
Annuals > 1 > balance Sheet > inventories
17683000
Annuals > 1 > balance Sheet > total Current Assets
347201000
Annuals > 1 > balance Sheet > property Plant Equipment
19361000
Annuals > 1 > balance Sheet > total Assets
693973000
Annuals > 1 > balance Sheet > payables
14637000
Annuals > 1 > balance Sheet > short Term Debt
7093000
Annuals > 1 > balance Sheet > long Term Debt
0
Annuals > 1 > balance Sheet > total Liabilities
235742000
Annuals > 1 > balance Sheet > equity
464066000
Annuals > 1 > balance Sheet > currency_symbol
USD
Annuals > 1 > cash Flow > net Income
-66628000
Annuals > 1 > cash Flow > depreciation
4933000
Annuals > 1 > cash Flow > change In Working Capital
13958000
Annuals > 1 > cash Flow > cash From Operations
-105917000
Annuals > 1 > cash Flow > capital Expenditures
245000
Annuals > 1 > cash Flow > cash From Investing
68991000
Annuals > 1 > cash Flow > cash From Financing
78141000
Annuals > 1 > cash Flow > net Change In Cash
41215000
Annuals > 1 > cash Flow > currency_symbol
USD
Annuals > 1 > ratios > PE
-0.23777197873173317
Annuals > 1 > ratios > PB
75.9021335583861
Annuals > 1 > ratios > ROE
-14.156822520934522
Annuals > 1 > ratios > ROA
-9.466794817665818
Annuals > 1 > ratios > FCF
-106162000
Annuals > 1 > ratios > Piotroski FScore
0
Annuals > 1 > ratios > fcf Percent
-141.54933333333332
Annuals > 1 > health Score
22
Annuals > 2 > quarter
2022-12-31
Annuals > 2 > income Statement > revenue
2090000
Annuals > 2 > income Statement > cost Of Revenue
152433000
Annuals > 2 > income Statement > gross Profit
-136815000
Annuals > 2 > income Statement > operating Expenses
60992000
Annuals > 2 > income Statement > operating Income
-197807000
Annuals > 2 > income Statement > interest Expense
3953000
Annuals > 2 > income Statement > pretax Income
-92783000
Annuals > 2 > income Statement > net Income
-50354000
Annuals > 2 > income Statement > eps
-0.17682996175350607
Annuals > 2 > income Statement > dividends Per Share
4025000
Annuals > 2 > income Statement > shares Outstanding
284759435
Annuals > 2 > income Statement > income Tax Expense
-55719000
Annuals > 2 > income Statement > EBITDA
-79937000
Annuals > 2 > income Statement > operating Margin
-9464.44976076555
Annuals > 2 > income Statement > total Other Income Expense Net
105024000
Annuals > 2 > income Statement > currency_symbol
USD
Annuals > 2 > balance Sheet > cash
149866000
Annuals > 2 > balance Sheet > short Term Investments
200229000
Annuals > 2 > balance Sheet > receivables
12317000
Annuals > 2 > balance Sheet > inventories
1
Annuals > 2 > balance Sheet > total Current Assets
386192000
Annuals > 2 > balance Sheet > property Plant Equipment
37238000
Annuals > 2 > balance Sheet > total Assets
702647000
Annuals > 2 > balance Sheet > payables
26503000
Annuals > 2 > balance Sheet > short Term Debt
12473000
Annuals > 2 > balance Sheet > long Term Debt
10244000
Annuals > 2 > balance Sheet > total Liabilities
155058000
Annuals > 2 > balance Sheet > equity
542220000
Annuals > 2 > balance Sheet > currency_symbol
USD
Annuals > 2 > cash Flow > net Income
-37065000
Annuals > 2 > cash Flow > depreciation
8893000
Annuals > 2 > cash Flow > change In Working Capital
15919000
Annuals > 2 > cash Flow > cash From Operations
-178792000
Annuals > 2 > cash Flow > capital Expenditures
2176000
Annuals > 2 > cash Flow > cash From Investing
-107223000
Annuals > 2 > cash Flow > cash From Financing
-29827000
Annuals > 2 > cash Flow > net Change In Cash
-315842000
Annuals > 2 > cash Flow > currency_symbol
USD
Annuals > 2 > ratios > PE
-0.17682996175350607
Annuals > 2 > ratios > PB
66.95013517146177
Annuals > 2 > ratios > ROE
-9.286636420641068
Annuals > 2 > ratios > ROA
-7.166329607896996
Annuals > 2 > ratios > FCF
-180968000
Annuals > 2 > ratios > Piotroski FScore
0
Annuals > 2 > ratios > fcf Percent
-86.58755980861244
Annuals > 2 > health Score
26
Annuals > 3 > quarter
2021-12-31
Annuals > 3 > income Statement > revenue
9979000
Annuals > 3 > income Statement > cost Of Revenue
110471000
Annuals > 3 > income Statement > gross Profit
-100492000
Annuals > 3 > income Statement > operating Expenses
57199000
Annuals > 3 > income Statement > operating Income
-150282000
Annuals > 3 > income Statement > interest Expense
4714000
Annuals > 3 > income Statement > pretax Income
-58953000
Annuals > 3 > income Statement > net Income
-60558000
Annuals > 3 > income Statement > eps
-0.21130462433285976
Annuals > 3 > income Statement > dividends Per Share
5957000
Annuals > 3 > income Statement > shares Outstanding
286590983
Annuals > 3 > income Statement > income Tax Expense
3756000
Annuals > 3 > income Statement > EBITDA
-46952000
Annuals > 3 > income Statement > operating Margin
-1505.9825633831044
Annuals > 3 > income Statement > total Other Income Expense Net
91329000
Annuals > 3 > income Statement > currency_symbol
USD
Annuals > 3 > balance Sheet > cash
465708000
Annuals > 3 > balance Sheet > short Term Investments
-
Annuals > 3 > balance Sheet > receivables
3589000
Annuals > 3 > balance Sheet > inventories
32513000
Annuals > 3 > balance Sheet > total Current Assets
501809000
Annuals > 3 > balance Sheet > property Plant Equipment
43936000
Annuals > 3 > balance Sheet > total Assets
946006000
Annuals > 3 > balance Sheet > payables
11345000
Annuals > 3 > balance Sheet > short Term Debt
9448000
Annuals > 3 > balance Sheet > long Term Debt
14261000
Annuals > 3 > balance Sheet > total Liabilities
361859000
Annuals > 3 > balance Sheet > equity
593515000
Annuals > 3 > balance Sheet > currency_symbol
USD
Annuals > 3 > cash Flow > net Income
-62709000
Annuals > 3 > cash Flow > depreciation
7287000
Annuals > 3 > cash Flow > change In Working Capital
861000
Annuals > 3 > cash Flow > cash From Operations
-158274000
Annuals > 3 > cash Flow > capital Expenditures
5661000
Annuals > 3 > cash Flow > cash From Investing
197375000
Annuals > 3 > cash Flow > cash From Financing
22727000
Annuals > 3 > cash Flow > net Change In Cash
61827000
Annuals > 3 > cash Flow > currency_symbol
USD
Annuals > 3 > ratios > PE
-0.21130462433285976
Annuals > 3 > ratios > PB
61.55731817191815
Annuals > 3 > ratios > ROE
-10.203280456264794
Annuals > 3 > ratios > ROA
-6.401439314338386
Annuals > 3 > ratios > FCF
-163935000
Annuals > 3 > ratios > Piotroski FScore
0
Annuals > 3 > ratios > fcf Percent
-16.427998797474697
Annuals > 3 > health Score
22
Valuation > metrics > PE
9.8308
Valuation > metrics > PB
85.84651554163973
Valuation > final Score
40
Valuation > verdict
1379.9% Overvalued
Profitability > metrics > ROE
-11.863820732761486
Profitability > metrics > ROA
-12.951961160086878
Profitability > metrics > Net Margin
-24.0977849810913
Profitability > final Score
0
Profitability > verdict
Weak
Risk > metrics > Debt Equity
0.48997140767338254
Risk > metrics > Interest Coverage
-20.122166246851386
Risk > final Score
-20
Risk > verdict
High
Liquidity > metrics > Current Ratio
27.14495152518326
Liquidity > metrics > Quick Ratio
27.14495152518326
Liquidity > final Score
100
Liquidity > verdict
Great
Prev Valuations > 0
40
Prev Valuations > 1
20
Prev Valuations > 2
20
Prev Profitabilities > 0
100
Prev Profitabilities > 1
0
Prev Profitabilities > 2
0
Prev Risks > 0
32
Prev Risks > 1
20
Prev Risks > 2
20
Prev Liquidities > 0
100
Prev Liquidities > 1
100
Prev Liquidities > 2
100
Updated At
2026-01-20T23:03:21.465Z
Earnings History > 0 > period
2026-03-31
Earnings History > 0 > report Date
2026-04-30
Earnings History > 0 > date
2026-03-31
Earnings History > 0 > before After Market
AfterMarket
Earnings History > 0 > currency
-
Earnings History > 0 > eps Actual
-
Earnings History > 0 > eps Estimate
-
Earnings History > 0 > eps Difference
0
Earnings History > 0 > surprise Percent
-
Earnings History > 1 > period
2025-06-30
Earnings History > 1 > report Date
2025-08-28
Earnings History > 1 > date
2025-06-30
Earnings History > 1 > before After Market
AfterMarket
Earnings History > 1 > currency
-
Earnings History > 1 > eps Actual
-0.19
Earnings History > 1 > eps Estimate
-
Earnings History > 1 > eps Difference
0
Earnings History > 1 > surprise Percent
-
Earnings History > 2 > period
2025-03-31
Earnings History > 2 > report Date
2025-04-30
Earnings History > 2 > date
2025-03-31
Earnings History > 2 > before After Market
-
Earnings History > 2 > currency
-
Earnings History > 2 > eps Actual
0.39
Earnings History > 2 > eps Estimate
0
Earnings History > 2 > eps Difference
0.39
Earnings History > 2 > surprise Percent
-
Earnings History > 3 > period
2024-06-30
Earnings History > 3 > report Date
2024-08-28
Earnings History > 3 > date
2024-06-30
Earnings History > 3 > before After Market
-
Earnings History > 3 > currency
-
Earnings History > 3 > eps Actual
-0.15
Earnings History > 3 > eps Estimate
0
Earnings History > 3 > eps Difference
-0.15
Earnings History > 3 > surprise Percent
-
Earnings History > 4 > period
2022-03-31
Earnings History > 4 > report Date
2022-04-26
Earnings History > 4 > date
2022-03-31
Earnings History > 4 > before After Market
-
Earnings History > 4 > currency
USD
Earnings History > 4 > eps Actual
0
Earnings History > 4 > eps Estimate
-0.2
Earnings History > 4 > eps Difference
0.2
Earnings History > 4 > surprise Percent
100
Earnings History > 5 > period
2021-06-30
Earnings History > 5 > report Date
2021-08-24
Earnings History > 5 > date
2021-06-30
Earnings History > 5 > before After Market
-
Earnings History > 5 > currency
USD
Earnings History > 5 > eps Actual
0
Earnings History > 5 > eps Estimate
-0.15
Earnings History > 5 > eps Difference
0.15
Earnings History > 5 > surprise Percent
100
Earnings History > 6 > period
2021-03-31
Earnings History > 6 > report Date
2021-04-15
Earnings History > 6 > date
2021-03-31
Earnings History > 6 > before After Market
-
Earnings History > 6 > currency
USD
Earnings History > 6 > eps Actual
0
Earnings History > 6 > eps Estimate
-0.2
Earnings History > 6 > eps Difference
0.2
Earnings History > 6 > surprise Percent
100
Earnings History > 7 > period
2020-06-30
Earnings History > 7 > report Date
2020-08-27
Earnings History > 7 > date
2020-06-30
Earnings History > 7 > before After Market
-
Earnings History > 7 > currency
USD
Earnings History > 7 > eps Actual
0
Earnings History > 7 > eps Estimate
-0.1
Earnings History > 7 > eps Difference
0.1
Earnings History > 7 > surprise Percent
100
Earnings History > 8 > period
2020-03-31
Earnings History > 8 > report Date
2020-04-09
Earnings History > 8 > date
2020-03-31
Earnings History > 8 > before After Market
-
Earnings History > 8 > currency
USD
Earnings History > 8 > eps Actual
0
Earnings History > 8 > eps Estimate
-0.2
Earnings History > 8 > eps Difference
0.2
Earnings History > 8 > surprise Percent
100
Earnings History > 9 > period
2019-03-31
Earnings History > 9 > report Date
2019-04-24
Earnings History > 9 > date
2019-03-31
Earnings History > 9 > before After Market
-
Earnings History > 9 > currency
USD
Earnings History > 9 > eps Actual
0
Earnings History > 9 > eps Estimate
-0.2
Earnings History > 9 > eps Difference
0.2
Earnings History > 9 > surprise Percent
100
Earnings History > 10 > period
2018-06-30
Earnings History > 10 > report Date
2018-08-28
Earnings History > 10 > date
2018-06-30
Earnings History > 10 > before After Market
-
Earnings History > 10 > currency
USD
Earnings History > 10 > eps Actual
0
Earnings History > 10 > eps Estimate
-0.2
Earnings History > 10 > eps Difference
0.2
Earnings History > 10 > surprise Percent
100
Earnings History > 11 > period
2018-03-31
Earnings History > 11 > report Date
2018-04-12
Earnings History > 11 > date
2018-03-31
Earnings History > 11 > before After Market
-
Earnings History > 11 > currency
USD
Earnings History > 11 > eps Actual
0.31
Earnings History > 11 > eps Estimate
0
Earnings History > 11 > eps Difference
0.31
Earnings History > 11 > surprise Percent
-
Earnings History > 12 > period
2017-06-30
Earnings History > 12 > report Date
2017-09-05
Earnings History > 12 > date
2017-06-30
Earnings History > 12 > before After Market
-
Earnings History > 12 > currency
USD
Earnings History > 12 > eps Actual
-0.18
Earnings History > 12 > eps Estimate
-0.1
Earnings History > 12 > eps Difference
-0.08
Earnings History > 12 > surprise Percent
-80
Earnings History > 13 > period
2017-03-31
Earnings History > 13 > report Date
2017-04-05
Earnings History > 13 > date
2017-03-31
Earnings History > 13 > before After Market
-
Earnings History > 13 > currency
USD
Earnings History > 13 > eps Actual
-0.08
Earnings History > 13 > eps Estimate
-0.1
Earnings History > 13 > eps Difference
0.02
Earnings History > 13 > surprise Percent
20
Earnings History > 14 > period
2016-06-30
Earnings History > 14 > report Date
2016-09-07
Earnings History > 14 > date
2016-06-30
Earnings History > 14 > before After Market
-
Earnings History > 14 > currency
USD
Earnings History > 14 > eps Actual
-0.13
Earnings History > 14 > eps Estimate
-0.1
Earnings History > 14 > eps Difference
-0.03
Earnings History > 14 > surprise Percent
-30
Earnings History > 15 > period
2016-03-31
Earnings History > 15 > report Date
2016-04-07
Earnings History > 15 > date
2016-03-31
Earnings History > 15 > before After Market
-
Earnings History > 15 > currency
USD
Earnings History > 15 > eps Actual
-0.33
Earnings History > 15 > eps Estimate
-0.1
Earnings History > 15 > eps Difference
-0.23
Earnings History > 15 > surprise Percent
-230
PureTech Health plc, engages in the development and commercialization of biotechnology and pharmaceutical solutions in the United States. It is developing LYT-100, which is under Phase 2 stage, to treat idiopathic pulmonary fibrosis (IPF); and LYT-200, a IgG4 monoclonal antibody, currently under Phase 1/2 stage, targeting galectin-9 for treating solid tumors and hematological malignancies. The company also develops SPT-300, an oral drug of allopregnanolone for the treatment of anxious depression; and delivers transformative medicines for patients with psychiatric and neurological conditions. In addition, the company develops hydrogels to enable the oral administration of peptide therapeutics in preclinical development; oral therapies based on defined bacterial consortia that is in phase 3 clinical stage; and engineering hematopoietic stem cells to enable targeted therapies for patients with blood cancers. Further, it develops voice-based technology platform that detects changes in the sound of voice that are linked with health conditions, including depression, anxiety, and respiratory disease. The company was incorporated in 2015 and is based in Boston, Massachusetts.
Stock Price
GBp 0.00
decrease compared to yesterday.
Dividend
Frequency:
Rate:
N/ANext Payout:
N/APureTech to Present at 44th Annual J.P. Morgan Healthcare Conference Business Wire
Read more →PureTech Appoints Robert Lyne as Chief Executive Officer Business Wire
Read more →Showing 2 of 10
(Last Updated 2025-06-30)
Rating:
BUY
$
Analyst Picks
Strong Buy
0
Buy
1
Hold
0
Sell
0
Strong Sell
0
(Last Updated 2025-06-30)
Health Score
Price to Earnings Ratio (P/E)
-
Very High
Low ≥ 50
High ≤ 10
Price to Book Ratio (P/B)
-
Very High
Low ≤ 1
High ≥ 3
Return on Equity (ROE)
-
Very Low
Low ≤ 5%
High ≥ 25%
Return on Assets (ROA)
-
Very Low
Low ≤ 2%
High ≥ 10%
Free Cash Flow - Revenue % (FCF)
-
Very Low
Low ≤ 5%
High ≥ 15%
Debt to Equity
-
High
Low ≥ 1
High ≤ 0.3
* Institutions hold a combined 0.00% of the total shares of PureTech Health plc
* Investors data is estimated based on stocks listed on Finnton that are currently held by Institution/Fund.
Date
2026-03-31
EPS Estimate
—
Date
2025-06-30
EPS Actual
-0.19
EPS Estimate
—
EPS Difference
0
Surprise Percent
0%
(Last Updated 2025-06-30)
(Last Updated 2025-06-30)
Revenue
£ 0
Cost Of Revenue
£ 0
Gross Profit
£ 0
Operating Expenses
£ 0
Operating Income
£ 0
Interest Expense
£ 0
Pretax Income
£ 0
Net Income
£ 0
Income Tax Expense
£ 0
EBITDA
£ 0
Total Other Income Expense Net
£ 0
Earnings Per Share
0
Dividends Per Share
0
Shares Outstanding
0
Operating Margin
0%
(Last Updated 2025-06-30)
Cash
£ 0
Short Term Investments
£ 0
Receivables
£ 0
Inventories
£ 0
Total Current Assets
£ 0
Property Plant Equipment
£ 0
Total Assets
£ 0
Payables
£ 0
Short Term Debt
£ 0
Long Term Debt
£ 0
Total Liabilities
£ 0
Equity
£ 0
(Last Updated 2025-06-30)
Net Income
£ 0
Depreciation
£ 0
Change In Working Capital
£ 0
Cash From Operations
£ 0
Capital Expenditures
£ 0
Cash From Investing
£ 0
Cash From Financing
£ 0
Net Change In Cash
£ 0
Disclaimer: Finnton is a stock screener tool provided for informational and educational purposes only. The data, analysis, and insights offered on this website do not constitute financial, investment, tax, or legal advice. Users are solely responsible for their own investment decisions, and Finnton makes no guarantees regarding the accuracy, completeness, or reliability of the information provided. Past performance is not indicative of future results. Always conduct your own research and consult with a licensed financial advisor before making any investment decisions.